Medicare Part D Coverage of Antiobesity Medications - Challenges and Uncertainty Ahead.

Baig, Khrysta; Dusetzina, Stacie B; Kim, David D; Leech, Ashley A

Baig, Khrysta; Dusetzina, Stacie B; Kim, David D; Leech, Ashley A.

Afiliação

Baig K; From the Department of Health Policy, Vanderbilt University School of Medicine, Nashville (K.B., S.B.D., A.A.L.), and the Department of Medicine, University of Chicago, Chicago (D.D.K.).
Dusetzina SB; From the Department of Health Policy, Vanderbilt University School of Medicine, Nashville (K.B., S.B.D., A.A.L.), and the Department of Medicine, University of Chicago, Chicago (D.D.K.).
Kim DD; From the Department of Health Policy, Vanderbilt University School of Medicine, Nashville (K.B., S.B.D., A.A.L.), and the Department of Medicine, University of Chicago, Chicago (D.D.K.).
Leech AA; From the Department of Health Policy, Vanderbilt University School of Medicine, Nashville (K.B., S.B.D., A.A.L.), and the Department of Medicine, University of Chicago, Chicago (D.D.K.).

N Engl J Med ; 388(11): 961-963, 2023 Mar 16.

Article em En | MEDLINE | ID: mdl-36912541

Assuntos

Fármacos Antiobesidade; Cobertura do Seguro; Medicare Part D; Idoso; Humanos; Cobertura do Seguro/economia; Medicare Part D/economia; Incerteza; Estados Unidos; Fármacos Antiobesidade/economia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Antiobesidade / Cobertura do Seguro / Medicare Part D Limite: Aged / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google